Virtual journey: ATTR amyloidosis

Written by Jameson Kowalczyk. Medically reviewed in March 2025.

Transthyretin amyloid cardiomyopathy is a condition that is caused by a buildup of abnormal protein deposits in the heart.

Left untreated, ATTR-CM is more likely to lead to serious complications and a lower quality of life.

Strategies that may help ease your out-of-pocket costs for treating transthyretin amyloid cardiomyopathy (ATTR-CM).

Strategies for caregivers of people with ATTR-CM when a treatment plan involves taking multiple medications.

A guide to three different types of amyloidosis, with a look at causes and underlying conditions.

How ATTR amyloidosis affects different organs, and what people with this condition need to know about treatment.

Living with and Treating ATTR Amyloidosis